Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translating Human Prototype Liver Implant Technology from Academia to Industry for Third-Party Transplant and In Vivo Validation.

Cells·2026
Same author

Revisiting the macrophage disappearance reaction.

Trends in immunology·2026
Same author

CD163 and Tim-4 identify resident intestinal macrophages that are spatially regulated by TGF-β.

The Journal of experimental medicine·2026
Same author

IL-4 treatment induces apoptosis of blood monocytes and proliferation of recruited injury-associated macrophages to resolve liver injury.

Cell reports·2026
Same author

MafB is a conserved transcriptional regulator of macrophage development and functional identity across tissues and species.

Immunity·2026
Same author

Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.

Science immunology·2026

Related Experiment Video

Updated: Jun 9, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

Targeting macrophages in liver fibrosis.

Lydia González Del Barrio1,2,3, David H Ipsen3, Dominik R Pfister3

  • 1Laboratory of Myeloid Cell Biology in Tissue Damage and Inflammation, VIB Center for Inflammation Research, VIB, Ghent, Belgium.

Frontiers in Immunology
|June 8, 2026
PubMed
Summary

Liver fibrosis, driven by excessive matrix buildup, involves dynamic macrophages. Therapeutic strategies now focus on reprogramming these macrophages towards restorative functions to reverse liver damage.

Keywords:
heterogeneityidentitykupffer cellslipid-associated macrophagesliver fibrosismacrophage-based therapiesmacrophagesplasticity

More Related Videos

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

Published on: May 9, 2025

A Simple and Efficient Method to Isolate Macrophages from Mixed Primary Cultures of Adult Liver Cells
08:10

A Simple and Efficient Method to Isolate Macrophages from Mixed Primary Cultures of Adult Liver Cells

Published on: May 24, 2011

Related Experiment Videos

Last Updated: Jun 9, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

Published on: May 9, 2025

A Simple and Efficient Method to Isolate Macrophages from Mixed Primary Cultures of Adult Liver Cells
08:10

A Simple and Efficient Method to Isolate Macrophages from Mixed Primary Cultures of Adult Liver Cells

Published on: May 24, 2011

Area of Science:

  • Immunology
  • Hepatology
  • Pathology

Background:

  • Fibrosis involves excessive extracellular matrix (ECM) deposition after chronic tissue injury, leading to organ dysfunction.
  • In the liver, fibrosis is a common outcome of chronic diseases like metabolic dysfunction-associated steatotic liver disease (MASLD).
  • Hepatic macrophages are key regulators of inflammation, immune responses, and tissue repair within the fibrotic liver microenvironment.

Purpose of the Study:

  • To review the diverse roles of hepatic macrophages in liver fibrosis.
  • To explore emerging therapeutic strategies targeting macrophages for liver fibrosis reversal.
  • To discuss the challenges and opportunities in developing macrophage-based anti-fibrotic therapies.

Main Methods:

  • Review of current literature on hepatic macrophage biology in fibrosis.
  • Analysis of macrophage heterogeneity and dynamic activation states beyond the M1/M2 paradigm.
  • Examination of therapeutic approaches including in situ reprogramming and cell-based therapies.

Main Results:

  • Hepatic macrophages exhibit complex, dynamic phenotypes in fibrosis, extending beyond classical classifications.
  • Liver fibrosis resolution is associated with macrophage reprogramming towards restorative functions (e.g., efferocytosis, matrix degradation).
  • Therapeutic strategies are evolving from inhibiting monocyte recruitment to actively promoting pro-resolution macrophage programs.

Conclusions:

  • Understanding the multifaceted hepatic macrophage landscape is crucial for developing effective anti-fibrotic therapies.
  • Targeting macrophage reprogramming offers promising avenues for potentially reversing liver fibrosis.
  • Further research is needed to optimize cell-based and in situ reprogramming strategies for clinical application.